A new enzyme said to rival pharmaceutical agents has been discovered and shows great potential in providing support for hypercoagulative states. A natural enzyme, Nattokinase, is derived from fermented soy and the bacteria Bacillus natto. Already, backed by research, this enzyme has showed great promise in areas such as cardiovascular disease, angina, venous stasis, thrombosis, emboli, stroke, atherosclerosis, fibromyalgia/chronic fatigue, claudication, hemorrhoids, varicose veins, retinal pathology, soft tissue rheumatisms, muscle spasm, poor healing, chronic inflammation and pain, peripheral vascular disease, hypertension, tissue oxygen deprivation, infertility, and other gynecological conditions (e.g. endometriosis, uterine fibroids).